What Is XDx?
XDx is a molecular diagnostics company focused on the discovery, development and commercialization of non-invasive gene expression testing in the areas of transplant medicine and autoimmunity. The company has developed a proprietary method of utilizing gene expression in blood that provides a new tool for physicians to manage the care of heart transplant patients.
The molecular expression technology developed and implemented by XDx in heart transplant patient management is currently being explored to assist with other diseases that involve the immune system.
Press Releases
XDx to Present at the 2008 In Vitro Diagnostic
Regulatory and Reimbursement Conference Nobember, 2008
XDx to Present at the Third Annual JMP Securities Healthcare Focus Conference October, 2008
FDA Clears Test to Help Doctors Manage Heart Transplant Patients August, 2008
XDx’s AlloMap® Gene Expression Test Cleared by U.S. Food and Drug Administration August, 2008
Personalized Medicine Coalition Announces Two New Board Members July, 2008